Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Gastrointestinal Malignant Tumor Resection
NCT04771637Completed
- Sponsor
- Yangzhou University
- Start
- Jan 2017
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in gastrointestinal cancer (4 arms), sponsored by Yangzhou University. Primary endpoints: Age, Weight and 3 more. Started Jan 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on NCT04771637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771637.